Home
About
Overview
Sharing Data
ORCID
Help
History (49)
Pineal Gland
Orbital malignancy in Papua New Guinea: a 21 year review.
Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease.
See All 49 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease.
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Antiparkinson Agents
Apomorphine
Dopamine
Double-Blind Method
Female
Humans
Larynx
Male
Middle Aged
Parkinson Disease
Speech
Treatment Outcome
authors with profiles
Sue Leurgans